Author:
Mercier Gustavo A.,Roy Felix-Nicolas,Bénard François
Publisher
Springer Berlin Heidelberg
Reference186 articles.
1. Adler L, Narayanan D, Gammage L, Beylin D, Keen R (2007) Quantitative improvement in breast lesion detectability on delayed images using high resolution positron emission mammography. J Nucl Med 48(S2):369P
2. Adler L, Weinberg I, Beylin D, Zavarzin V, Yarnall S, Stepanov P, et al. (2005) Positron Emission Mammography: High-Resolution Biochemical Breast Imaging. Technol Cancer Res Trea 4(1):55-60
3. Anderson WF, Matsuno R (2006) Breast Cancer Heterogeneity: A Mixture of At Least Two Main Types. J Natl Cancer Inst 98(14):948−951
4. Alberini J, Lerebours F, Wartski M, Fourme E, Stanc EL, Gontier E et al (2009) 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer 115(21):5038–5047
5. Arlinghaus LR, Li X, Levy M, Smith D, Welch EB, Gore JC et al (2010) Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy. J Oncol [Internet] [cited 5 Jan 2011]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20953332